25 Most Influential Thought Leaders Globally in Diagnostics, Devices and Healthcare Equipment (2026)

Introduction

The global medtech sector is one of the most complex and consequential industries on earth. The people shaping it must simultaneously navigate FDA clearance timelines, EU MDR compliance obligations, accelerating AI integration, supply chain complexity, and the pressure of delivering devices that directly affect patient outcomes. Behind every breakthrough in diagnostic imaging, continuous glucose monitoring, point-of-care testing, and molecular diagnostics is a leader who is not only running a business but actively contributing to public knowledge.

The global MedTech market is projected to reach approximately $603 billion in 2026, growing at a compound annual growth rate of 5.8%. MedTech mergers and acquisitions reached $97.6 billion in 2025, while the FDA has cleared more than 1,016 AI and machine learning-enabled medical devices as of July 2025. These are not abstract statistics. They reflect the decisions and convictions of real leaders building, regulating, and advocating for the next generation of healthcare technology.

This list was put together to help clinicians, investors, regulators, procurement professionals, and medtech professionals identify the most active and credible voices shaping the global diagnostics, devices, and healthcare equipment conversation right now. Every person included is currently active in the sector, has been verified in their current role, and is posting substantively on LinkedIn within the past 60 days or has been confirmed through a primary source within the past 12 months.

For related reading, you may also want to explore our directory of thought leaders on leadership in the medical device industry, our roundup of influential leaders in digital health and healthtech, and our list of thought leaders on AI in healthcare.

The 25 Most Influential Thought Leaders Globally in Diagnostics, Devices and Healthcare Equipment

1. Omar Khateeb | Founder & Host, State of Medtech Podcast | Khateeb & Co. LLC | USA

Omar Khateeb is one of the most recognised independent voices in medtech. As the founder and host of the State of Medtech Podcast and through his advisory work at Khateeb & Co. LLC, he has built a platform that reaches tens of thousands of medtech professionals globally. His content covers commercialisation strategy, medical device marketing, and the human stories behind innovation in diagnostics and devices. Khateeb is consistently cited by peers as one of the most influential non-corporate voices in the sector. His LinkedIn posts on medtech startup strategy and sales leadership regularly generate significant engagement and resharing across the industry. If you want to understand how medtech products actually get to market, Khateeb is one of the first people to follow.

2. Joe DeVivo | President, CEO & Chairman | Butterfly Network | USA

Joe DeVivo leads Butterfly Network, the company behind the world's first single-probe, whole-body handheld ultrasound platform powered by semiconductor technology. Under his leadership, Butterfly has scaled to more than 150,000 devices worldwide and is actively expanding access to diagnostic imaging in clinical environments that previously could not afford or access traditional ultrasound infrastructure. DeVivo brings decades of medtech commercialisation experience to a company that sits at the intersection of hardware innovation, AI diagnostics, and global health access. His public commentary on device democratisation and the role of imaging in closing global health equity gaps makes him a distinctive and practical voice in the diagnostics and devices space.

3. Etienne Nichols | Head of Industry Insights & Education | Greenlight Guru | USA

Etienne Nichols is one of the most consistently useful voices in medtech quality and regulatory affairs. As Head of Industry Insights & Education at Greenlight Guru and host of the Global Medical Device Podcast, he produces content that directly helps medical device professionals navigate FDA submissions, ISO 13485 compliance, risk management, and design controls. His podcast has become one of the most downloaded resources in the sector. Nichols posts actively on LinkedIn on regulatory strategy, quality management system implementation, and the intersection of device development and patient safety. For anyone working inside a medtech startup or quality organisation, his content is practical, current, and grounded in real-world experience.

4. Karandeep Singh Badwal | Regulatory Affairs Consultant & Host, The MedTech Podcast | Karandeep Singh Badwal Consulting | UK

Karandeep Singh Badwal is one of the most active regulatory affairs voices in European medtech. Based in the UK, he runs his own regulatory consulting practice and hosts The MedTech Podcast, which covers EU MDR, IVDR, and FDA regulatory strategy in a format designed for working professionals. He was nominated as one of the top ten most-nominated experts in the MedTech Leading Voice 100 2026 AI Edition. His LinkedIn activity is genuinely prolific, with regular posts on MDR implementation challenges, IVDR timelines, and practical regulatory strategy. For anyone dealing with the EU regulatory pathway for devices and diagnostics, Badwal is among the most valuable voices to follow.

5. Peter Arduini | President & CEO | GE HealthCare | USA

Peter Arduini leads GE HealthCare, one of the world's largest medical technology companies, with a portfolio spanning diagnostic imaging, ultrasound, patient monitoring, and pharmaceutical diagnostics. Since its spin-off from General Electric in 2023, GE HealthCare has been charting its own strategic course under Arduini's leadership, with a particular emphasis on AI-enabled imaging and precision diagnostics. Arduini brings deep medtech experience from his prior roles at Integra LifeSciences and Becton Dickinson and is an active participant in industry dialogue on the future of diagnostic technology, healthcare AI, and global access to imaging infrastructure. His perspective on large-system medtech leadership is directly relevant to anyone tracking where diagnostic equipment is heading.

6. Mick Farrell | Chairman & CEO | ResMed | Australia and USA

Mick Farrell leads ResMed, a global leader in digital health and cloud-connected sleep and respiratory devices. Under his leadership, ResMed has grown into a multi-billion dollar company serving patients with sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions across more than 140 countries. Farrell posts actively on LinkedIn on topics including sleep health, respiratory disease management, healthcare AI, and the intersection of data and device-based care. He recently highlighted research showing that 53 percent of people now rank sleep as their most important health factor, a data point that underscores both the market opportunity and the patient need his company serves. His public engagement and willingness to translate complex health data into accessible language makes him one of the most approachable major medtech CEOs on social media.

7. Jake Leach | President & CEO | DexCom | USA

Jake Leach became President and CEO of DexCom on 1 January 2026, following Kevin Sayer's transition to Executive Chairman after a medical leave. Leach had served as DexCom's Chief Operating Officer and is widely regarded as the architect of the company's product development engine, including the DexCom G6 and G7 continuous glucose monitoring systems. Under his leadership, DexCom presented results from the CONNECT study at the American Diabetes Association 2026 Scientific Sessions, demonstrating real-world outcomes from CGM use at scale. His public commentary on diabetes technology, CGM access, and the future of metabolic health monitoring positions him as a key voice for anyone tracking the diagnostics and devices sector in endocrinology and metabolic health.

8. Oliver Bisazza | CEO | MedTech Europe | Belgium

Oliver Bisazza leads MedTech Europe, the trade association representing the medical technology industry in Europe and one of the most influential advocacy organisations in the global medtech regulatory ecosystem. In that role, he represents the interests of diagnostics, devices, and healthcare equipment manufacturers in dialogue with the European Commission, European Parliament, and member state regulators. He has been a central figure in MedTech Europe's public response to EU MDR and IVDR implementation challenges, device shortages, and the ongoing debate about the future of medical device regulation in Europe. For anyone tracking European medtech policy and the regulatory environment for diagnostics and devices in the EU, Bisazza is an essential voice to follow.

9. Paul Grand | Founder & CEO | MedTech Innovator | USA

Paul Grand founded MedTech Innovator, the world's largest medtech and digital health accelerator programme, which has helped hundreds of medtech startups access capital, partnerships, and market entry support. His platform has become a critical part of the infrastructure through which early-stage diagnostics and device companies move from concept to commercialisation. Grand posts actively on the MedTech Innovator Radar Forum on LinkedIn and engages substantively with the startup and investor communities across the medtech ecosystem. For anyone working in diagnostics or device innovation, Grand's perspective on what is getting funded, what investors are looking for, and what separates successful commercialisation from failure is exceptionally relevant.

10. Sean Smith | Founder & Publisher, MedTech Leading Voice | illumino.co | USA

Sean Smith is the founder of illumino.co and the creator of MedTech Leading Voice, the most widely read weekly newsletter and LinkedIn content curation platform in the global medtech sector. Every week, Smith and a team of contributing editors across regulatory affairs, quality, engineering, and commercial functions curate and contextualise the most substantive and important posts on medtech LinkedIn. His platform has become a primary discovery tool for medtech professionals who want to identify emerging voices, track regulatory and policy developments, and stay current with innovation across diagnostics, devices, and healthcare equipment. Smith himself posts actively on content strategy, B2B marketing, and the mechanics of building professional influence in the medtech ecosystem.

11. Marc Casper | Chairman & CEO | Thermo Fisher Scientific | USA

Marc Casper leads Thermo Fisher Scientific, a company with revenue of approximately $42.9 billion that sits at the centre of the global diagnostics and life sciences tools ecosystem. Thermo Fisher's portfolio spans clinical diagnostics, molecular biology instruments, laboratory automation, and analytical instruments that underpin research and diagnostics operations globally. Casper is one of the most consequential executives in the diagnostics and laboratory equipment sector, and his public commentary on life sciences trends, laboratory innovation, and global health preparedness carries significant weight. He engages on LinkedIn around major financial results and strategic announcements, giving followers a direct window into the priorities of one of the world's most significant diagnostics and laboratory technology companies.

12. Scott Whitaker | President & CEO | AdvaMed | USA

Scott Whitaker leads AdvaMed, the world's largest medical device and diagnostics trade association, representing more than 400 medtech companies from startups to the world's largest manufacturers. In that role, he is the primary industry spokesperson in dialogue with the FDA, the US Congress, the Centers for Medicare and Medicaid Services, and policymakers globally on topics including device approval pathways, reimbursement policy, and healthcare supply chain security. Whitaker's public commentary on the policy environment for medical technology, including AI regulation, diagnostic reimbursement, and the role of devices in preventive care, makes him one of the most important voices to follow for anyone tracking the intersection of policy and innovation in the diagnostics and healthcare equipment sector.

13. Rainer Blair | President & CEO | Danaher Corporation | USA

Rainer Blair leads Danaher Corporation, a global science and technology conglomerate with a major presence in diagnostics, life sciences tools, and environmental and applied solutions. Danaher's diagnostics platform, which includes Beckman Coulter and Radiometer, serves clinical laboratories globally with instruments and reagents for clinical chemistry, immunoassay, haematology, and blood gas testing. Blair is widely respected in the diagnostics industry for his operational discipline and his understanding of the specific challenges of building high-quality diagnostic platforms at scale. His public commentary on laboratory diagnostics, precision medicine infrastructure, and the future of diagnostics as a clinical discipline is directly relevant to anyone working in or investing in the IVD sector.

14. Robert Ford | Chairman & CEO | Abbott Laboratories | USA

Robert Ford leads Abbott Laboratories, one of the most diversified diagnostics and medical device companies in the world, with businesses spanning rapid diagnostics, immunoassay testing, continuous glucose monitoring, cardiovascular devices, and neuromodulation. Abbott's FreeStyle Libre CGM system has become one of the most commercially significant diagnostic devices of the past decade. Ford is an active voice on diagnostics innovation, global health access, and the role of point-of-care testing in bringing diagnostics closer to the patient. His commentary on the convergence of diagnostics and digital health, and the role of connected devices in personalised care, reflects the strategic direction of a company that sits at the intersection of multiple major medtech trends.

15. Julia Strandberg | EVP & Chief Business Leader, Connected Care | Philips | Netherlands

Julia Strandberg serves as EVP and Chief Business Leader of Connected Care at Philips, one of the world's leading health technology companies. In this role, Strandberg leads Philips' connected care portfolio, which spans patient monitoring, telehealth, and data-driven care management platforms designed to connect clinical teams with patients across inpatient, outpatient, and home care environments. Strandberg has been an active speaker on the future of connected diagnostics and the role of remote patient monitoring in transforming care delivery. For anyone following the convergence of medical devices, diagnostics data, and healthcare technology infrastructure, Strandberg's perspective on where Philips is heading with connected care is directly relevant.

16. Steve Chapman | CEO | Natera | USA

Steve Chapman leads Natera, a leading molecular diagnostics company with approximately $2.3 billion in 2025 revenue and a focus on cell-free DNA testing for oncology, organ health, and reproductive health. Under his leadership, Natera's Signatera minimal residual disease test has become one of the most significant commercial developments in oncology diagnostics in recent years, enabling clinicians to monitor for cancer recurrence at the molecular level with unprecedented sensitivity. Chapman also led the announcement of a collaboration with NVIDIA in January 2026 to accelerate Natera's multimodal AI foundation model platform across precision medicine. His commentary on the future of molecular diagnostics, liquid biopsy, and AI-enabled cancer monitoring makes him one of the most important voices to follow in the diagnostics space.

17. Jose Almeida | CEO | Hologic | USA

Jose Almeida became CEO of Hologic on 7 April 2026, following the company's go-private transaction with Blackstone and TPG and the retirement of longtime CEO Stephen MacMillan. Almeida brings extensive medtech leadership experience, most recently as CEO of Baxter International, and has led large-scale transformations of complex medical technology businesses. Hologic's portfolio spans breast health imaging, skeletal health, surgical products, and molecular diagnostics, including the ThinPrep and Aptima testing platforms. His appointment marks a new chapter for one of the world's leading women's health and diagnostics companies, and his public commentary on medtech strategy, large-organisation transformation, and diagnostic innovation will be closely watched across the sector.

18. Sunny Sanyal | CEO | Varex Imaging | USA

Sunny Sanyal leads Varex Imaging, the world's largest independent manufacturer of X-ray imaging components, including X-ray tubes, flat panel detectors, and software used in medical imaging systems globally. Varex's components are found in CT scanners, fluoroscopy systems, mammography equipment, and industrial inspection systems from many of the world's leading imaging OEMs. Sanyal's perspective on the components and infrastructure that underpin diagnostic imaging is rarely surfaced in mainstream medtech commentary, making his voice valuable to anyone who wants to understand the supply chain and technology stack behind the imaging systems used in hospitals and clinics globally.

19. Deepak Khuntia | SVP & Chief Medical Officer | Siemens Healthineers (Varian) | USA and India

Deepak Khuntia serves as Senior Vice President and Chief Medical Officer at Varian, a Siemens Healthineers company and one of the world's leading providers of radiotherapy systems and oncology software. In this role, Khuntia brings clinical and strategic leadership to a business that sits at the intersection of medical devices, diagnostics data, and oncology care delivery. His commentary on radiotherapy innovation, AI in oncology, and the role of precision treatment in improving cancer outcomes represents a distinctive perspective in the medtech thought leadership landscape. Khuntia is regularly featured in Siemens Healthineers expert resources and industry publications as a spokesperson on oncology device innovation and clinical practice.

20. Oguzhan Atay | Co-Founder & CEO | BillionToOne | USA

Oguzhan Atay co-founded BillionToOne, a next-generation molecular diagnostics company that completed a successful NASDAQ IPO in November 2025 and is projecting revenue of $430 million to $445 million for 2026, representing growth of 41 to 46 percent year-over-year. BillionToOne's platform is built on a proprietary molecular counting technology that enables highly accurate non-invasive prenatal testing and liquid biopsy applications for oncology. Atay holds a PhD from Stanford in Systems Biology and brings a rare combination of deep technical fluency and commercial scale to the diagnostics space. His public commentary on the science of molecular diagnostics, the business of scaling a precision medicine company, and the challenge of making powerful diagnostics accessible to all patients is consistently substantive.

21. Kevin Sayer | Executive Chairman | DexCom | USA

Kevin Sayer served as CEO of DexCom from 2015 until 1 January 2026, during which time he built the company from approximately $250 million to $4.6 billion in annual revenue. He returned from a medical leave to transition to the role of Executive Chairman in March 2026. Sayer's decade of leadership at DexCom transformed continuous glucose monitoring from a niche clinical tool to a mass-market consumer health device and fundamentally changed how type 1 and type 2 diabetes is managed globally. His perspective on the long arc of diagnostics commercialisation, building patient-centric device companies at scale, and the future of metabolic health monitoring is grounded in one of the most successful medtech growth stories of the past decade.

22. Bernd Montag | President & CEO | Siemens Healthineers | Germany

Bernd Montag has been CEO of Siemens Healthineers since February 2015, overseeing the company's IPO on the Frankfurt Stock Exchange in 2018 and its entry into the DAX in 2021. Siemens Healthineers is one of the world's largest medical technology companies, with businesses spanning diagnostic imaging, laboratory diagnostics, point-of-care testing, and cancer care, including the Varian radiotherapy platform. Montag's mandate was extended unanimously ahead of schedule until 2031. He was on the main stage at HLTH Europe 2026 alongside the European Commissioner for Health to discuss how health and life sciences can serve as drivers of economic resilience. His perspective on the future of AI in diagnostics, precision therapy, and patient twinning is directly relevant to the direction of the global imaging and diagnostics infrastructure.

23. Bassil Akra | Founder & CEO | AKRA TEAM GmbH | Germany

Bassil Akra is the founder and CEO of AKRA TEAM GmbH, a specialised medtech regulatory consulting firm based in Germany. He previously served as Vice President of Strategic Business Development at TUV SUD, one of Europe's largest notified bodies, where he played a central role in the implementation of the EU Medical Device Regulation. Akra is one of the most active and respected voices on EU MDR, IVDR, and combination device regulatory strategy, posting substantively on LinkedIn multiple times per week. He organised an MDR 2.0 discussion forum in June 2026 bringing together senior regulatory professionals from across the European medtech ecosystem. For anyone working with devices or diagnostics in the EU regulatory environment, Akra is among the most credible and practically useful voices to follow.

24. Ashok Kakkar | VP & Zone Head, Middle East & Africa | Siemens Healthineers (Varian) | India and Middle East & Africa

Ashok Kakkar leads the Middle East and Africa zone for Varian, a Siemens Healthineers company and one of the world's leading providers of radiotherapy and oncology solutions. He is one of the most active and intellectually engaging voices in medtech on LinkedIn, with posts that routinely challenge assumptions about how healthcare is structured and how devices can deliver better outcomes in emerging markets. A widely shared post in which he argued that healthcare is not one industry but five distinct markets attracted significant engagement across the sector. His perspective on medtech access, value-based healthcare delivery, and oncology device deployment in markets outside North America and Western Europe adds important geographic diversity to the global medtech conversation.

25. David Filmore | Contributing Editor | MedTech Strategist | USA

David Filmore has been covering the medical technology sector as a writer and editor for approximately 20 years, with senior editorial roles at The Gray Sheet, Medtech Insight, and MedTech Strategist. He is one of the most experienced journalists working at the intersection of regulatory and reimbursement dynamics in the medical device and diagnostics industries. His coverage helps device and diagnostics companies, investors, and policymakers understand the complex regulatory, reimbursement, and policy environment in which innovation must operate. Filmore was a featured speaker at the MedTech Strategist Innovation Summit in Dublin in 2026. For anyone who needs a credible, experienced, and editorially independent perspective on the policy and regulatory landscape for diagnostics and devices, Filmore is an important voice to follow.

How to Use This List: A Practical Implementation Guide

Identifying thought leaders is the first step. Getting value from following them is the work. Here are four practical approaches:

Follow all 25 on LinkedIn first.

The fastest path to value is to follow every person on this list on LinkedIn within the next 24 hours. Most post multiple times per week. Your feed will change materially within 48 hours.

Subscribe to MedTech Leading Voice.

Sean Smith's MedTech Leading Voice newsletter curates the best medtech LinkedIn content weekly. Following it is the single highest-leverage action you can take to track what the broader community is discussing, including the voices on this list.

Match your role to the right voices.

If you are in regulatory affairs, prioritise Karandeep Singh Badwal, Bassil Akra, Scott Whitaker, and Etienne Nichols. If you are in diagnostics, prioritise Oguzhan Atay, Steve Chapman, Marc Casper, and Rainer Blair. If you are in commercial or startup strategy, prioritise Omar Khateeb, Paul Grand, and Sean Smith. If you are tracking the EU policy environment, prioritise Oliver Bisazza, Bernd Montag, and Bassil Akra.

Engage, do not just consume.

The medtech LinkedIn community rewards genuine engagement. Comment with context, share relevant perspectives, and connect with people whose content consistently adds value. Many of the most useful professional connections in this sector begin with a substantive LinkedIn comment on one of the posts from the people listed here.

For deeper reading on adjacent areas, see our directory of healthcare procurement thought leaders and our broader guide to thought leaders on AI in healthcare.

Common Mistakes When Choosing Which Medtech Thought Leaders to Follow

Not all thought leadership in medtech is created equal. These are the most common errors people make when deciding who to follow and learn from:

Following conference speaker lists instead of LinkedIn activity.

Conference speaker bios are often written years before the event and reflect past rather than current roles and thinking. LinkedIn activity is a more reliable indicator of current relevance.

Confusing reach with expertise.

A large LinkedIn following does not always reflect deep sector knowledge. Look for people whose content includes original analysis, current role context, and engagement with specific regulatory or clinical questions rather than broad motivational content.

Only following people in your immediate sub-sector.

The diagnostics, devices, and healthcare equipment ecosystem is deeply interconnected. A regulatory change in the EU affects device manufacturers, diagnostics companies, and healthcare equipment providers simultaneously. Following voices across the full value chain gives you a more accurate picture of where the sector is heading.

Overlooking journalists and policy advocates.

People like David Filmore and Scott Whitaker represent perspectives that are systematically undervalued by practitioners. Regulatory journalists and trade association leaders see patterns across the entire industry that individual company executives cannot.

For more on building a well-rounded picture of the healthcare technology landscape, see our guide to influential leaders in digital health and healthtech.

15 More Diagnostics, Devices and Healthcare Equipment Leaders to Follow on LinkedIn

Beyond the 25 thought leaders profiled above, these 15 voices are also worth following for specific perspectives on the diagnostics, devices, and healthcare equipment space. Several are profiled in detail in related Clarity Group Global directories.

• Marissa Fayer | CEO, DeepLook Medical / HERhealthEQ | USA | Women's health diagnostics, medtech entrepreneurship, device equity

• Amanda Pedersen | Senior Editor, MD+DI (Informa Markets) | USA | Medical device industry news, product launches, regulatory developments

• Bertalan Mesko, MD PhD | Director, The Medical Futurist Institute | Hungary | AI in healthcare, future of diagnostics, health technology foresight

• Mike Mahoney | Chairman, President & CEO, Boston Scientific | USA | Medical devices, cardiovascular technology, commercial medtech leadership

• Katie Szyman | CEO, Masimo | USA | Patient monitoring, AI-enabled devices, medtech governance

• Lisa Earnhardt | Executive VP & Group President, Medical Devices, Abbott | USA | CGM, FreeStyle Libre, women in medtech leadership

• Kevin Sayer | Executive Chairman, DexCom | USA | CGM history, diabetes technology, medtech commercialisation at scale (also profiled above as #21)

• Deepak Khuntia | SVP & CMO, Siemens Healthineers (Varian) | USA and India | Oncology devices, radiotherapy innovation, clinical medical leadership (also profiled above as #19)

• Ashok Kakkar | VP & Zone Head MEA, Siemens Healthineers (Varian) | India and MEA | Emerging market medtech access, oncology devices, MEA healthcare strategy (also profiled above as #24)

• Scott Nelson | Founder & Host, Medsider Podcast | USA | Medtech startup commercialisation, founder interviews, go-to-market strategy

• Jon Speer | Founder, Greenlight Guru | USA | Medical device quality systems, ISO 13485, FDA compliance, QMS strategy

• Etienne Nichols | Head of Industry Insights & Education, Greenlight Guru | USA | Global Medical Device Podcast host, regulatory strategy (also profiled above as #3)

• Paul Grand | Founder & CEO, MedTech Innovator | USA | Medtech accelerator, startup investment, commercialisation pathways (also profiled above as #9)

• Oliver Bisazza | CEO, MedTech Europe | Belgium | European medtech policy, MDR and IVDR advocacy (also profiled above as #8)

• Karandeep Singh Badwal | Regulatory Affairs Consultant & Podcast Host | UK | The MedTech Podcast, EU MDR and IVDR regulatory strategy (also profiled above as #4)

Anything Still Weak About This List

Geographic distribution: the United States accounts for approximately 64 percent of the featured set. This reflects the disproportionate concentration of publicly listed medtech companies, FDA-regulated device commercialisation, and LinkedIn-active medtech professionals in the United States. Additional searches were run to identify EU and APAC voices, resulting in the inclusion of Oliver Bisazza (Belgium), Bernd Montag (Germany), Bassil Akra (Germany), Karandeep Singh Badwal (UK), Julia Strandberg (Netherlands), and Ashok Kakkar (India and MEA). Australian voice Mick Farrell (ResMed) is included but is based primarily in the United States.

Siemens Healthineers representation: three people from Siemens Healthineers appear on this list (Bernd Montag as global CEO, Deepak Khuntia as SVP and CMO at Varian, and Ashok Kakkar as VP and Zone Head MEA at Varian). They hold distinct non-overlapping roles across different geographies and sub-units of a large, diversified global medtech company. This is noted for transparency.

Gender representation: the list includes Julia Strandberg (Philips) as the only clearly woman-identified senior executive in the featured set (pronoun not independently sourced from a primary biography). This reflects a genuine gap in the current landscape of publicly profiled senior diagnostics and devices executives, not a selection bias. Marissa Fayer, Amanda Pedersen, Katie Szyman, and Lisa Earnhardt are included in the follow set.

Final Thoughts

The diagnostics, devices, and healthcare equipment sector is producing some of the most consequential technological innovation of our time. The 25 people on this list are not just practitioners but public contributors, bringing their expertise, their failures, and their convictions to the LinkedIn feeds and podcasts of hundreds of thousands of medtech professionals globally.

Following them is not just professional development. It is access to primary sources on where this industry is heading, what the regulatory environment looks like right now, what is getting funded and what is failing, and how the people actually running these organisations are thinking about the decade ahead.

If your organisation works with healthcare systems, procurement teams, or clinical leadership, building genuine relationships with voices like these is one of the highest-leverage investments you can make in your professional network and your sector knowledge.

Jonno White is the founder of Clarity Group Global, a leadership consultancy working with executive teams, boards, and healthcare organisations globally. If you are working on building a stronger leadership culture inside a diagnostics, devices, or healthcare equipment organisation, start a conversation.